The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Asim Amin, Hans Hammers
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2019-01-01
Serie:Frontiers in Immunology
Ämnen:
combination immunotherapy
VEGF inhibition
immune check point inhibitor
advanced renal cell carcinoma
immuno modulation
Länkar:https://www.frontiersin.org/article/10.3389/fimmu.2018.03120/full
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk